As of June 21, 2025, LBT Innovations Ltd (LBT.AX) reports a Net Margin of -285.50%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of LBT Innovations Ltd's Net Margin
Over recent years, LBT Innovations Ltd's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-06-30 | -285.50% |
| 2023-06-30 | -1048.12% |
| 2022-06-30 | -291.27% |
| 2021-06-30 | -506.28% |
| 2020-06-30 | -321.87% |
This slight downward trend highlights how LBT Innovations Ltd manages its overall profitability and cost control over time.
Comparing LBT Innovations Ltd's Net Margin to Peers
To better understand LBT Innovations Ltd's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| LBT Innovations Ltd (LBT.AX) | -285.50% |
| Cochlear Ltd (COH.AX) | 15.96% |
| Orcoda Ltd (ODA.AX) | 3.57% |
| Resonance Health Ltd (RHT.AX) | 1.92% |
| Compumedics Ltd (CMP.AX) | -0.68% |
| Somnomed Ltd (SOM.AX) | -13.35% |
Compared to its competitors, LBT Innovations Ltd's Net Margin is about average compared to peers, reflecting typical industry profitability.